PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein, 403015, GD, Rotterdam, The Netherlands.\', \'Fundacio Institut Universitari per a la recerca a l\'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.\', \'Department of Veterans Affairs, University of Utah, Salt Lake City, UT, USA.\', \'Department of Biomedical Informatics, Columbia University, New York, NY, USA.\', \'School of Public Health and Community Medicine, UNSW, Sydney, Australia.\', \'Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.\', \'Department of Big Data Strategy, National Health Insurance Service, Wonju, Republic of Korea.\', \'Tufts University School of Medicine, Institute for Clinical Research and Health Policy Studies, Boston, MA, 02111, USA.\', \'Independent Epidemiologist, OHDSI, Rotterdam, The Netherlands.\', \'So Ahn Public Health Center, Wando County Health Center and Hospital, Wando, Republic of Korea.\', \'Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.\', \'Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK.\', \'Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Republic of Korea.\', \'Center for Surgical Science, Koege, Denmark.\', \'Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.\', \'Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark.\', \'NNF Centre for Protein Research, University of Copenhagen, Copenhagen, Denmark.\', \'Abbvie, Chicago, USA.\', \'Real World Solutions, IQVIA, Cambridge, MA, USA.\', \'Janssen Latin America, Buenos Aires, Argentina.\', \'Department of Veterans Affairs, Washington D. C, USA.\', \'Vanderbilt University, Nashville, USA.\', \'Division of Population Health and Genomics, University of Dundee, Dundee, UK.\', \'School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.\', \'Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.\', \'Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, Australia.\', \'Janssen Research & Development, Titusville, NJ, USA.\', \'Bayer Pharmaceuticals, Bayer Hispania, S.L., Barcelona, Spain.\', \'Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.\', \'Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.\', \'Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA.\', \'School of Public Health, Peking Union Medical College, Beijing, China.\', \'Melbourne School of Public Health, The University of Melbourne, Melbourne, Victoria, Australia.\', \'Department of Medical Informatics, Erasmus University Medical Center, Doctor Molewaterplein, 403015, GD, Rotterdam, The Netherlands. p.rijnbeek@erasmusmc.nl.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12874-022-01505-z
?:hasPublicationType
?:journal
  • BMC medical research methodology
is ?:pmid of
?:pmid
?:pmid
  • 35094685
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.221
?:rankingScore_hIndex
  • 88
is ?:relation_isRelatedTo_publication of
?:title
  • Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all